Skip to content

A randomized controlled trial of transcranial magnetic stimulation and robotic-hand therapy to improve hand function after ischemic stroke

A randomized controlled trial of transcranial magnetic stimulation and robotic-hand therapy to improve hand function after ischemic stroke

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13003417
Enrollment
Unknown
Registered
2013-08-06
Start date
2013-07-01
Completion date
Unknown
Last updated
2017-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ischemic stroke

Interventions

Two groups:transcranial magnetic stimulation & robotic-hand therapy 10 sessions for TBS, 20 sessions for robotic-hand therapy versus sham transcranial magnetic stimulation

Sponsors

Division of Neurology, Department of Medicine & Therapeutics, The Chinese University of Hong Kong
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1) patients aged 18 or above; 2) first-ever ischemic subcortical stroke with onset time less than 21 days; 3) hand weakness as a result of stroke; 4) intracerebral hemorrhage excluded by brain computed tomography (CT) / magnetic resonance imaging (MRI); 5) the patient or his/her legally acceptable representative is willing to provide written informed consent.

Exclusion criteria

Exclusion criteria: 1) personal history of epilepsy; 2) metallic implants in any part of body; 3) implanted cardiac pacemaker, defibrillator, medication pump or any other implanted electronics; 4) severe skull fracture, serious head injury, history of brain or spinal cord surgery; 5) brain tumour or other significant non-ischemic brain lesion on CT/MRI; 6) administration of drugs that potentially lower seizure threshold; 7) severe hand spasticity, open hand wound or hand deformity; 8) history of malignancy; 9) severe co-existing systemic diseases, severe dementia or psychosis; 10) inability to be followed up at regular interval; 11) pregnancy or breast-feeding.

Design outcomes

Primary

MeasureTime frame
Upper limb fugl-meyer assessment (FMA);

Secondary

MeasureTime frame
RMT, AMT, MEP, S/R curve, Power Grip, Lateral Pinch Grip, Purdue Pegboard for both hands, NIHSS, mRS;

Countries

China

Contacts

Public ContactKa Sing WONG

Division of Neurology, Dept of Medicine and Therapeutics, PWH

ks-wong@cuhk.edu.hk+852 2632 3877

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026